| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.11 | 6e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.0001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |